Based on previous studies showing an association between higher f-Hb concentrations and increased CRC risk [21,22], high f-Hb concentration may also increase the yield of UGI evaluations among FIT+/CRC− patients. The gene discussed is GSTM1; the disease is colorectal carcinoma.